APA

Smilde T. D. J., Linssen G. C. M., Gallemann D., Kuhn T., Machnig T., Mol P. G. M., Hillege H. L., Van Wijk L. M., Van Dijk R. B. & Van Veldhuisen D. J. (20060126). Influence of renal dysfunction on the pharmacokinetics of the selective Na+/H+ exchange inhibitor EMD 87 580 in patients with chronic heart failure. : International journal of clinical pharmacology and therapeutics.

Chicago

Smilde T D J, Linssen G C M, Gallemann D, Kuhn T, Machnig T, Mol P G M, Hillege H L, Van Wijk L M, Van Dijk R B and Van Veldhuisen D J. 20060126. Influence of renal dysfunction on the pharmacokinetics of the selective Na+/H+ exchange inhibitor EMD 87 580 in patients with chronic heart failure. : International journal of clinical pharmacology and therapeutics.

Harvard

Smilde T. D. J., Linssen G. C. M., Gallemann D., Kuhn T., Machnig T., Mol P. G. M., Hillege H. L., Van Wijk L. M., Van Dijk R. B. and Van Veldhuisen D. J. (20060126). Influence of renal dysfunction on the pharmacokinetics of the selective Na+/H+ exchange inhibitor EMD 87 580 in patients with chronic heart failure. : International journal of clinical pharmacology and therapeutics.

MLA

Smilde T D J, Linssen G C M, Gallemann D, Kuhn T, Machnig T, Mol P G M, Hillege H L, Van Wijk L M, Van Dijk R B and Van Veldhuisen D J. Influence of renal dysfunction on the pharmacokinetics of the selective Na+/H+ exchange inhibitor EMD 87 580 in patients with chronic heart failure. : International journal of clinical pharmacology and therapeutics. 20060126.